Onconova Therapeutics announces reverse stock split
Onconova Therapeutics announced a one-for-fifteen reverse stock split of its common stock, effective September 25, 2018. Beginning on September 26, 2018, Onconova’s common stock will trade on the Nasdaq Capital Market on a split-adjusted basis. September 25, 2018